For example, the paper authors say we do not have more than enough concrete information about the correct benefits of microdosing vs . placebo effects, challenges of microdosing, or what dose is sufficient to create benefits. Ross et al39 stated that a little sample dimension can be a limitation on the demo, referring to their randomized Managemen